Abstract Parkinson's disease (PD), although being the second most prevalent
neurodegenerative disease (ND) encounters lack of definitive treatment and challenges in …

Parkinson's disease (PD) is a progressive neurodegenerative disorder that exerts a huge
burden on our society. The occurrence of this neurodegenerative disease has been …

Parkinson's disease (PD) is an extrapyramidal, chronic progressive neurodegenerative
disorder. It affects approximately 5 million individuals globally, and by 2030, the prevalence …

Parkinson's disease (PD) affects around ten million people worldwide and is considered the
second most prevalent neurodegenerative disease after Alzheimer's disease. In addition …

Neurodegenerative disorders are consequences of the deterioration of cells and tissues with
a mature undesirable way of life. The degenerative disease like Parkinson's disease (PD) …

Current treatments for Parkinson's disease (PD) are aimed at addressing motor symptoms
but there is no therapy focused on modifying the course of the disease. Successful treatment …

Highlights•We describe the main clinical manifestations and pathogenesis of Parkinson's
disease.•We present a general overview of current treatments for Parkinson's disease.•We …

Parkinson's disease (PD) is believed to be one of the commonly found adult-onset
movement disorder occurring due to neurodegeneration and striatal dopamine deficiency …

Nanoparticles might be produced and manipulated to present a large spectrum of
properties. The physicochemical features of the engineered nanomaterials confer to them …

Although effective symptomatic treatments for Parkinson's disease (PD) have been available
for some time, efficient and well-controlled drug delivery to the brain has proven to be …